Prevention of catheter-related bloodstream infection in patients on hemodialysis

Nature Reviews Nephrology

Volumn 7, Issue 5, 2011, Pages 257-265

  Betjes, Michiel G H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BACITRACIN PLUS POLYMYXIN B; CHLORHEXIDINE; CITRATE SODIUM; CITRATE TRISODIUM; HEPARIN; MINOCYCLINE; POVIDONE IODINE; PSEUDOMONIC ACID; RIFAMPICIN; SALICYLIC ACID; TAUROLIDINE;

ANTIBACTERIAL ACTIVITY; ASEPSIS; BACTERIUM CONTAMINATION; BIOFILM; CATHETER CARE; CATHETER INFECTION; CENTRAL VEIN; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DISINFECTION; ERADICATION THERAPY; FEMORAL VEIN; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYGIENE; INFECTION PREVENTION; INFECTION RISK; JUGULAR VEIN; MATERIAL COATING; MEDICAL RECORD; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; RISK REDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUBCLAVIAN VEIN;

CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CROSS INFECTION; EDUCATION, MEDICAL, CONTINUING; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 79955595063     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2011.28     Document Type: Review

References (101)

1. Pisoni, R. L. et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 61, 305-316 (2002). (Pubitemid 34075158)
2. Dittmer, I. D., Sharp, D., McNulty, C. A., Williams, A. J. & Banks, R. A. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin. Nephrol. 51, 34-39 (1999). (Pubitemid 29027404)
3. Engemann, J. J. et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect. Control Hosp. Epidemiol. 26, 534-539 (2005). (Pubitemid 40896143)
4. Moist, L. M., Trpeski, L., Na, Y. & Lok, C. E. Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian organ replacement registry 2001-2004. Clin. J. Am. Soc. Nephrol. 3, 1726-1732 (2008).
5. Rayner, H. C. & Pisoni, R. L. The increasing use of hemodialysis catheters: evidence from the DOPPS on its significance and ways to reverse it. Semin. Dial. 23, 6-10 (2010).
6. Rabindranath, K. S. et al. Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol. Dial. Transplant. 24, 3763-3774 (2009).
7. Tokars, J. I., Miller, E. R. & Stein, G. New national surveillance system for hemodialysis-associated infections: initial results. Am. J. Infect. Control 30, 288-295 (2002). (Pubitemid 34852414)
8. Raad, I. et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J. Infect. Dis. 168, 400-407 (1993). (Pubitemid 23210618)
9. Bach, A. et al. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit. Care Med. 27, 515-521 (1999). (Pubitemid 29162671)
10. O'Grady, N. P. et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm. Rep. 51, 1-29 (2002).
11. Davies, D. G. et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280, 295-298 (1998). (Pubitemid 28178075)
12. Asad, S. & Opal, S. M. Bench-to-bedside review: quorum sensing and the role of cell-to-cell communication during invasive bacterial infection. Crit. Care 12, 236 (2008).
13. Rasmussen, T. B. & Givskov, M. Quorum sensing inhibitors as anti-pathogenic drugs. Int. J. Med. Microbiol. 296, 149-161 (2006). (Pubitemid 43375998)
14. Pronovost, P. et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N. Engl. J. Med. 355, 2725-2732 (2006). (Pubitemid 46021509)
15. Beathard, G. A. & Urbanes, A. Infection associated with tunneled hemodialysis catheters. Semin. Dial. 21, 528-538 (2008).
16. Warren, D. K. et al. The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. Chest 126, 1612-1618 (2004). (Pubitemid 39525038)
17. Coopersmith, C. M. et al. The impact of bedside behavior on catheter-related bacteremia in the intensive care unit. Arch. Surg. 139, 131-136 (2004). (Pubitemid 38174704)
18. Beathard, G. A. Catheter management protocol for catheter-related bacteremia prophylaxis. Semin. Dial. 16, 403-405 (2003). (Pubitemid 37347013)
19. Pronovost, P. J. et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ 340, c309 (2010).
20. Murphy, D. J. et al. Monitoring and reducing central line-associated bloodstream infections: a national survey of state hospital associations. Am. J. Med. Qual. 25, 255-260 (2010).
21. Rodriguez-Paz, J. M. & Pronovost, P. Prevention of catheter-related bloodstream infections. Adv. Surg. 42, 229-248 (2008).
22. Rubinson, L., Wu, A. W., Haponik, E. E. & Diette, G. B. Why is it that internists do not follow guidelines for preventing intravascular catheter infections? Infect. Control Hosp. Epidemiol. 26, 525-533 (2005). (Pubitemid 40896142)
23. Mermel, L. A. Prevention of intravascular catheter-related infections. Ann. Intern. Med. 132, 391-402 (2000). (Pubitemid 30127778)
24. Raad, I. I. et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect. Control Hosp. Epidemiol. 15, 231-238 (1994).
25. Chaiyakunapruk, N., Veenstra, D. L., Lipsky, B. A. & Saint, S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann. Intern. Med. 136, 792-801 (2002). (Pubitemid 34568649)
26. McKee, R., Dunsmuir, R., Whitby, M. & Garden, O. J. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition? J. Hosp. Infect. 6, 419-425 (1985). (Pubitemid 16199573)
27. Ranson, M. R., Oppenheim, B. A., Jackson, A., Kamthan, A. G. & Scarffe, J. H. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J. Hosp. Infect. 15, 95-102 (1990). (Pubitemid 20123908)
28. Tordoir, J. et al. EBPG on vascular access. Nephrol. Dial. Transplant. 22 (Suppl. 2), ii88-ii117 (2007).
29. Vanholder, R. et al. Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): a position statement of the European Renal Best Practice (ERBP). NDT Plus 3, 234-246 (2010).
30. Randolph, A. G., Cook, D. J., Gonzales, C. A. & Brun-Buisson, C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit. Care Med. 26, 1452-1457 (1998). (Pubitemid 28384650)
31. Timsit, J. F. et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 276, 1416-1420 (1996).
32. Atapour, A., Shahidi, S. & Sairafian, S. H. Does tunneling the temporary vascular access extend its lifetime? J. Res. Med. Sci. 11, 41-47 (2006). (Pubitemid 44335890)
33. Weijmer, M. C., Vervloet, M. G. & ter Wee, P. M. Prospective follow-up of a novel design haemodialysis catheter; lower infection rates and improved survival. Nephrol. Dial. Transplant. 23, 977-983 (2008). (Pubitemid 351767583)
34. Betjes, M. G. & van Agteren, M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol. Dial. Transplant. 19, 1546-1551 (2004). (Pubitemid 38786749)
35. Weijmer, M. C. et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J. Am. Soc. Nephrol. 16, 2769-2777 (2005).
36. Deshpande, K. S. et al. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit. Care Med. 33, 13-20 (2005). (Pubitemid 40116531)
37. Hamilton, H. C. & Foxcroft, D. R. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD004084. doi:10.1002/14651858.CD004084.pub2 (2007). (Pubitemid 351805457)
38. Parienti, J. J. et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299, 2413-2422 (2008).
39. Agarwal, A. K., Patel, B. M. & Haddad, N. J. Central vein stenosis: a nephrologist's perspective. Semin. Dial. 20, 53-62 (2007).
40. Hernández, D. et al. Subclavian vascular access stenosis in dialysis patients: natural history and risk factors. J. Am. Soc. Nephrol. 9, 1507-1510 (1998). (Pubitemid 28354562)
41. Vanholder, R. et al. Catheter-related blood stream infections (CRBSI): a European view. Nephrol. Dial. Transplant. 25, 1753-1756 (2010).
42. Luebke, M. A. et al. Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am. J. Infect. Control 26, 437-441 (1998). (Pubitemid 28381730)
43. Menyhay, S. Z. & Maki, D. G. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors. Am. J. Infect. Control 36, S174.e1-S174.e5 (2008).
44. Blake, M. Update: catheter-related bloodstream infection rates in relation to clinical practice and needleless device type. Can. J. Infect. Control 23, 156-162 (2008).
45. Jean, G. et al. Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 91, 399-405 (2002). (Pubitemid 34765237)
46. Gillies, D. et al. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD003827. doi:10.1002/14651858.CD003827 (2003).
47. Le Corre, I., Delorme, M. & Cournoyer, S. A prospective, randomized trial comparing a transparent dressing and a dry gauze on the exit-site of long term central venous catheters of hemodialysis patients. J. Vasc. Access 4, 56-61 (2003). (Pubitemid 36926504)
48. Camins, B. C. et al. A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis. Infect. Control Hosp. Epidemiol. 31, 1118-1123 (2010).
49. Ho, K. M. & Litton, E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J. Antimicrob. Chemother. 58, 281-287 (2006). (Pubitemid 44294936)
50. Jaffer, Y., Selby, N. M., Taal, M. W., Fluck, R. J. & McIntyre, C. W. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am. J. Kidney Dis. 233-241 (2008).
51. James, M. T. et al. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann. Intern. Med. 148, 596-605 (2008). (Pubitemid 351669133)
52. Yahav, D. et al. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin. Infect. Dis. 47, 83-93 (2008). (Pubitemid 351920592)
53. Polaschegg, H. D. & Sodemann, K. Risks related to catheter locking solutions containing concentrated citrate. Nephrol. Dial. Transplant. 18, 2688-2690 (2003).
54. Punt, C. D. & Boer, W. E. Cardiac arrest following injection of concentrated trisodium citrate. Clin. Nephrol. 69, 317-318 (2008). (Pubitemid 351516280)
55. US Food and Drug Administration. FDA issues warning on tricitrasol dialysis catheter anticoagulant. FDA talk paper TOO-16 (14 April 2000).
56. Willicombe, M. K., Vernon, K. & Davenport, A. Embolic complications from central venous hemodialysis catheters used with hypertonic citrate locking solution. Am. J. Kidney Dis. 55, 348-351 (2010).
57. Moran, J. E. & Ash, S. R. Locking solutions for hemodialysis catheters; heparin and citrate-a position paper by ASDIN. Semin. Dial. 21, 490-492 (2008).
58. Grudzinski, L., Quinan, P., Kwok, S. & Pierratos, A. Sodium citrate 4% locking solution for central venous dialysis catheters-an effective, more cost-efficient alternative to heparin. Nephrol. Dial. Transplant. 22, 471-476 (2007). (Pubitemid 46189891)
59. Lok, C. E., Appleton, D., Bhola, C., Khoo, B. & Richardson, R. M. Trisodium citrate 4%-an alternative to heparin capping of haemodialysis catheters. Nephrol. Dial. Transplant. 22, 477-483 (2007). (Pubitemid 46189892)
60. Weijmer, M. C., Debets-Ossenkopp, Y. J., Van De Vondervoort, F. J. & ter Wee, P. M. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking. Nephrol. Dial. Transplant. 17, 2189-2195 (2002). (Pubitemid 35446677)
61. Balestrino, D. et al. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol. Dial. Transplant. 24, 3204-3209 (2009).
62. Takla, T. A., Zelenitsky, S. A. & Vercaigne, L. M. Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. J. Antimicrob. Chemother. 62, 1024-1026 (2008).
63. Bleyer, A. J., Mason, L., Russell, G., Raad, I. I. & Sherertz, R. J. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect. Control Hosp. Epidemiol. 26, 520-524 (2005). (Pubitemid 40896141)
64. McCann, M. & Moore, Z. E. H. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD006894. doi:10.1002/14651858.CD006894.pub2 (2010).
65. Johnson, D. W. et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J. Am. Soc. Nephrol. 16, 1456-1462 (2005). (Pubitemid 41716531)
66. Quadri, K. & Huraib, S. Manuka honey for central venous catheter exit-site care. Semin. Dial. 12, 397-398 (1999).
67. Kamalia, M. D., Haris, Y. A. & Zaki, S. M. Role of topical mupirocin as a prophylaxis in catheter related infection in haemodialysis patients. Int. Med. J. 11, 41-46 (2004). (Pubitemid 38585683)
68. Johnson, D. W. et al. A randomized controlled trial of topical exit-site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol. Dial. Transplant. 17, 1802-1807 (2002). (Pubitemid 35174293)
69. Sesso, R. et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J. Am. Soc. Nephrol. 9, 1085-1092 (1998). (Pubitemid 28264737)
70. Levin, A., Mason, A. J., Jindal, K. K., Fong, I. W. & Goldstein, M. B. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int. 40, 934-938 (1991).
71. Lok, C. E. et al. Hemodialysis infection prevention with polysporin ointment. J. Am. Soc. Nephrol. 14, 169-179 (2003). (Pubitemid 36026307)
72. Zakrzewska-Bode, A., Muytjens, H. L., Liem, K. D. & Hoogkamp-Korstanje, J. A. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J. Hosp. Infect. 31, 189-193 (1995).
73. Hurdle, J. G., O'Neill, A. J., Mody, L., Chopra, I. & Bradley, S. F. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J. Antimicrob. Chemother. 56, 1166-1168 (2005). (Pubitemid 43009843)
74. Miller, M. A., Dascal, A., Portnoy, J. & Mendelson, J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect. Control Hosp. Epidemiol. 17, 811-813 (1996). (Pubitemid 126478535)
75. Gilbert, R. E. & Harden, M. Effectiveness of impregnated central venous catheters for catheter related blood stream infection: a systematic review. Curr. Opin. Infect. Dis. 21, 235-245 (2008). (Pubitemid 351620377)
76. Veenstra, D. L., Saint, S., Saha, S., Lumley, T. & Sullivan, S. D. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 281, 261-267 (1999). (Pubitemid 29058116)
77. Chatzinikolaou, I. et al. Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am. J. Med. 115, 352-357 (2003). (Pubitemid 37311251)
78. Dahlberg, P. J. et al. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect. Control Hosp. Epidemiol. 16, 506-511 (1995).
79. Trerotola, S. O. et al. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection-a randomized study. Radiology 207, 491-496 (1998).
80. Vandecasteele, S. J., Boelaert, J. R. & De Vriese, A. S. Staphylococcus aureus infections in hemodialysis: what a nephrologist should know. Clin. J. Am. Soc. Nephrol. 4, 1388-1400 (2009).
81. Summers, S. A., Gupta, R. K., Clutterbuck, E. J., Laing, C. & Cooke, G. S. Haemodialysis catheter-associated infection: common pathogens in unusual places. Nephrol. Dial. Transplant. 20, 2287-2288 (2005). (Pubitemid 41510117)
82. von Eiff, C. et al. Nasal carriage as source of Stapylococcus aureus bacteremia. Study Group. N. Engl. J. Med. 344, 11-16 (2001). (Pubitemid 32064839)
83. Chow J. W. & Yu, V. L. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. Arch. Intern. Med. 149, 1258-1262 (1989). (Pubitemid 19163516)
84. Boelaert, J. R. et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol. Dial. Transplant. 4, 278-281 (1989). (Pubitemid 19155472)
85. Boelaert, J. R. et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol. Dial. Transplant. 8, 235-239 (1993). (Pubitemid 23122975)
86. van Rijen, M., Bonten, M., Wenzel, R. & Kluytmans, J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD006216. doi:10.1002/14651858.CD006216.pub2 (2008).
87. Yu, V. L. et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N. Engl. J. Med. 315, 91-96 (1986). (Pubitemid 16093211)
88. Boelaert, J. R. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. J. Chemother. 6 (Suppl. 2), 19-24 (1994). (Pubitemid 24257527)
89. Bloom, B. S., Fendrick, A. M., Chernew, M. E. & Patel, P. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. Am. J. Kidney Dis. 27, 687-694 (1996). (Pubitemid 26135841)
90. Peña, C. et al. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization. J. Hosp. Infect. 58, 20-27 (2004). (Pubitemid 39207107)
91. Scully, B. E., Briones, F., Gu, J. W. & Neu, H. C. Mupirocin treatment of nasal staphylococcal colonization. Arch. Intern. Med. 152, 353-356 (1992).
92. Doebbeling, B. N. et al. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage. Arch. Intern. Med. 154, 1505-1508 (1994). (Pubitemid 24208576)
93. Doebbeling, B. N. et al. Elimination of Staphylococcus aureus nasal carriage in health care workers: analysis of six clinical trials with calcium mupirocin ointment. The mupirocin collaborative study group. Clin. Infect. Dis. 17, 466-474 (1993). (Pubitemid 23261465)
94. Kluytmans, J. A., Manders, M. J., van Bommel, E. & Verbrugh, H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect. Control Hosp. Epidemiol. 17, 793-797 (1996). (Pubitemid 126478531)
95. Watanakunakorn, C. et al. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. Am. J. Infect. Control 20, 138-141 (1992).
96. Holton, D. L., Nicolle, L. E., Diley, D. & Bernstein, K. Efficacy of mupirocin nasal ointment in eradicating Staphylococcus aureus nasal carriage in chronic haemodialysis patients. J. Hosp. Infect. 17, 133-137 (1991).
97. Sedlacek, M., Gemery, J. M., Cheung, A. L., Bayer, A. S. & Remillard, B. D. Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am. J. Kidney Dis. 49, 401-408 (2007).
98. Pronovost, P. Interventions to decrease catheter-related bloodstream infections in the ICU: the keystone intensive care unit project. Am. J. Infect. Control 36, S171.e1-S171.e5 (2008).
99. Power, A. et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am. J. Kidney Dis. 53, 1034-1041 (2009).
100. Abbas, S. A. et al. Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report. Am. J. Kidney Dis. 53, 492-502 (2009).
101. Lemaire, X. et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif. 28, 21-28 (2009).